A Giant Frontal Meningioma with Psychiatric Symptoms in a Young Woman: A Case Report
International Clinical Neuroscience Journal,
Vol. 8 No. 2 (2021),
27 March 2021
,
Page 99-102
Abstract
Background:Frontal meningioma is often asymptomatic but patients might experience psychiatric symptoms. Since symptoms are atypical in giant meningioma, to the best of our knowledge, we present a rare clinical scenario.
Case Presentation: A 24-year old female patient with no medical history presented with two months of depressive symptoms, personality changes such as easy irritability, and feelings of frustration and mental depression, as well as forgetfulness and blurred vision. Brain magnetic resonance imaging (MRI) revealed a well-defined markedly enhancing lesion in the left frontal region measuring 65 x 70 x 70 mm with mass effects to the adjacent brain tissue and associated surrounding edema which was pressed to the frontal horn of the lateral ventricle. The patient underwent frontal unilateral craniotomy and excision of the tumor. After surgery, the quality of life was improved.
Conclusion: Meningioma with psychiatric symptoms is quite rare. This clinical case helps clinicians avoid missing symptoms and use appropriate management strategies for patients with giant meningiomas.
- Atypical psychiatric symptoms
- Giant meningioma
- Unilateral frontal craniotomy
How to Cite
References
Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99(3):307-14. doi: 10.1007/s11060-010-0386-3.
Mumoli N, Pulerà F, Vitale J, Camaiti A. Frontal lobe syndrome caused by a giant meningioma presenting as depression and bipolar disorder. Singapore Med J. 2013;54(8):e158-9. doi: 10.11622/smedj.2013160.
Yakhmi S, Sidhu BS, Kaur J, Kaur A. Diagnosis of frontal meningioma presenting with psychiatric symptoms. Indian J Psychiatry. 2015;57(1):91-3. doi: 10.4103/0019- 5545.148534.
Prabhu VC, Perry EC, Melian E, Barton K, Guo R, Anderson DE. Intracranial meningiomas in individuals under the age of 30; analysis of risk factors, histopathology, and recurrence rate. Neuroscience Discovery. 2014;2(1):1-15. doi: 10.7243/2052- 6946-2-1.
Gupta RK, Kumar R. Benign brain tumours and psychiatric morbidity: a 5-years retrospective data analysis. Aust N Z J Psychiatry. 2004;38(5):316-9. doi: 10.1080/j.1440- 1614.2004.01357.x.
Caroli E, Russillo M, Ferrante L. Intracranial meningiomas in children: report of 27 new cases and critical analysis of 440 cases reported in the literature. J Child Neurol. 2006;21(1):31- 6. doi: 10.1177/08830738060210010801.
Vadivelu S, Sharer L, Schulder M. Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy. J Neurosurg. 2010;112(5):920- 4. doi: 10.3171/2009.8.jns09201.
Pravdenkova S, Al-Mefty O, Sawyer J, Husain M. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg. 2006;105(2):163-73. doi: 10.3171/jns.2006.105.2.163.
Simon M, Boström JP, Hartmann C. Molecular genetics of meningiomas: from basic research to potential clinical applications. Neurosurgery. 2007;60(5):787-98. doi: 10.1227/01.neu.0000255421.78431.ae.
Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med. 1988;319(16):1033- 9. doi: 10.1056/nejm198810203191601.
Sadetzki S, Flint-Richter P, Starinsky S, Novikov I, Lerman Y, Goldman B, et al. Genotyping of patients with sporadic and radiation-associated meningiomas. Cancer Epidemiol Biomarkers Prev. 2005;14(4):969-76. doi: 10.1158/1055- 9965.epi-04-0366.
Bommakanti K, Gaddamanugu P, Alladi S, Purohit AK, Chadalawadi SK, Mekala S, et al. Pre-operative and post-operative psychiatric manifestations in patients with supratentorial meningiomas. Clin Neurol Neurosurg. 2016;147:24-9. doi: 10.1016/j.clineuro.2016.05.018.
Lampl Y, Barak Y, Achiron A, Sarova-Pinchas I. Intracranial meningiomas: correlation of peritumoral edema and psychiatric disturbances. Psychiatry Res. 1995;58(2):177-80. doi: 10.1016/0165-1781(95)02586-l.
d’Avella E, Volpin F, Manara R, Scienza R, Della Puppa A. Indocyanine green videoangiography (ICGV)-guided surgery of parasagittal meningiomas occluding the superior sagittal sinus (SSS). Acta Neurochir (Wien). 2013;155(3):415-20. doi: 10.1007/s00701-012-1617-5.
Richard SA, Shrestha SS, Zhang C, Fu W, Wang T, Cong W, et al. Successful treatment of a child with ruptured arteriovenous malformation using onyx embolization: a case report. Open J Mod Neurosurg. 2017;07(04):153-63. doi: 10.4236/ ojmn.2017.74016.
Abramovich CM, Prayson RA. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Hum Pathol. 1998;29(12):1420-7. doi: 10.1016/ s0046-8177(98)90010-7.
Roser F, Samii M, Ostertag H, Bellinzona M. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien). 2004;146(1):37-44. doi: 10.1007/s00701-003-0173-4.
Nakasu S, Fukami T, Jito J, Matsuda M. Microscopic anatomy of the brain-meningioma interface. Brain Tumor Pathol. 2005;22(2):53-7. doi: 10.1007/s10014-005-0187-0.
Hahn HP, Bundock EA, Hornick JL. Immunohistochemical staining for claudin-1 can help distinguish meningiomas from histologic mimics. Am J Clin Pathol. 2006;125(2):203-8. doi: 10.1309/g659-fvvb-mg7u-4rpq.
Andrews BT, Dujovny M, Mirchandani HG, Ausman JI. Microsurgical anatomy of the venous drainage into the superior sagittal sinus. Neurosurgery. 1989;24(4):514-20. doi: 10.1227/00006123-198904000-00005.
Khu KJ, Ng I, Ng WH. The relationship between parasagittal and falcine meningiomas and the superficial cortical veins: a virtual reality study. Acta Neurochir (Wien). 2009;151(11):1459-64. doi: 10.1007/s00701-009-0379-1.
- Abstract Viewed: 418 times
- PDF Downloaded: 434 times